Diagnos Laboratorium (Indonesia) Buy Hold or Sell Recommendation
| DGNS Stock | IDR 220.00 4.00 1.79% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Diagnos Laboratorium Utama is 'Cautious Hold'. The recommendation algorithm takes into account all of Diagnos Laboratorium's available fundamental, technical, and predictive indicators you will find on this site.
Check out Diagnos Laboratorium Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Diagnos and provide practical buy, sell, or hold advice based on investors' constraints. Diagnos Laboratorium Utama. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Diagnos |
Execute Diagnos Laboratorium Buy or Sell Advice
The Diagnos recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Diagnos Laboratorium Utama. Macroaxis does not own or have any residual interests in Diagnos Laboratorium Utama or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Diagnos Laboratorium's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Cautious Hold
Market Performance | Very Weak | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Moves totally opposite to the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Diagnos Laboratorium Trading Alerts and Improvement Suggestions
| Diagnos Laboratorium generated a negative expected return over the last 90 days | |
| Diagnos Laboratorium has high historical volatility and very poor performance | |
| About 80.0% of the company shares are held by company insiders |
Diagnos Laboratorium Returns Distribution Density
The distribution of Diagnos Laboratorium's historical returns is an attempt to chart the uncertainty of Diagnos Laboratorium's future price movements. The chart of the probability distribution of Diagnos Laboratorium daily returns describes the distribution of returns around its average expected value. We use Diagnos Laboratorium Utama price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Diagnos Laboratorium returns is essential to provide solid investment advice for Diagnos Laboratorium.
| Mean Return | -0.44 | Value At Risk | -5.45 | Potential Upside | 6.03 | Standard Deviation | 3.47 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Diagnos Laboratorium historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Diagnos Laboratorium Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Diagnos Laboratorium or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Diagnos Laboratorium's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Diagnos stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.34 | |
β | Beta against Dow Jones | -0.82 | |
σ | Overall volatility | 3.52 | |
Ir | Information ratio | -0.17 |
Diagnos Laboratorium Volatility Alert
Diagnos Laboratorium Utama exhibits very low volatility with skewness of 0.08 and kurtosis of 3.16. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure Diagnos Laboratorium's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact Diagnos Laboratorium's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.Diagnos Laboratorium Fundamentals Vs Peers
Comparing Diagnos Laboratorium's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Diagnos Laboratorium's direct or indirect competition across all of the common fundamentals between Diagnos Laboratorium and the related equities. This way, we can detect undervalued stocks with similar characteristics as Diagnos Laboratorium or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Diagnos Laboratorium's fundamental indicators could also be used in its relative valuation, which is a method of valuing Diagnos Laboratorium by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Diagnos Laboratorium to competition |
| Fundamentals | Diagnos Laboratorium | Peer Average |
| Return On Equity | 0.0603 | -0.31 |
| Return On Asset | 0.0297 | -0.14 |
| Profit Margin | 0.06 % | (1.27) % |
| Operating Margin | 0.06 % | (5.51) % |
| Current Valuation | 967.86 B | 16.62 B |
| Shares Outstanding | 1.25 B | 571.82 M |
| Shares Owned By Insiders | 80.00 % | 10.09 % |
| Price To Earning | 10.49 X | 28.72 X |
| Price To Sales | 1.60 X | 11.42 X |
| Revenue | 302.18 B | 9.43 B |
| Gross Profit | 148.56 B | 27.38 B |
| EBITDA | 19.21 B | 3.9 B |
| Net Income | 64.3 B | 570.98 M |
| Cash And Equivalents | 52.8 B | 2.7 B |
| Cash Per Share | 42.24 X | 5.01 X |
| Total Debt | 10.45 B | 5.32 B |
| Debt To Equity | 0.01 % | 48.70 % |
| Current Ratio | 7.26 X | 2.16 X |
| Book Value Per Share | 171.17 X | 1.93 K |
| Cash Flow From Operations | 58.87 B | 971.22 M |
| Earnings Per Share | 51.84 X | 3.12 X |
| Number Of Employees | 568 | 18.84 K |
| Beta | 0.89 | -0.15 |
| Market Capitalization | 302.5 B | 19.03 B |
| Total Asset | 241.98 B | 29.47 B |
| Z Score | 17.8 | 8.72 |
| Annual Yield | 0.02 % | |
| Net Asset | 241.98 B |
Diagnos Laboratorium Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Diagnos . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Diagnos Laboratorium Buy or Sell Advice
When is the right time to buy or sell Diagnos Laboratorium Utama? Buying financial instruments such as Diagnos Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Diagnos Laboratorium in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Chemicals Thematic Idea Now
Chemicals
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Chemicals theme has 61 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Chemicals Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Diagnos Stock
Diagnos Laboratorium financial ratios help investors to determine whether Diagnos Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Diagnos with respect to the benefits of owning Diagnos Laboratorium security.